单位(元)华夏恒生香港上市生物科技ETF(QDII)(159892)资产负债表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
资产 |
银行存款 |
16,368,856 |
31,809,246 |
3,846,056 |
1,502,228 |
结算备付金 |
145,059 |
28,936,442 |
633,823 |
7,710,931 |
存出保证金 |
216,914 |
278,920 |
337,054 |
403,443 |
交易性金融资产 |
2,833,491,211 |
1,190,082,667 |
532,980,175 |
159,641,570 |
其中:股票投资 |
2,833,491,211 |
1,190,082,667 |
532,980,175 |
159,641,570 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
8,136,720 |
- |
291 |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
2,807,428 |
- |
569,707 |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
- |
- |
- |
资产总计 |
2,858,358,759 |
1,253,914,702 |
537,797,399 |
169,827,879 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
1,497 |
43,546,974 |
81 |
3,344,086 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,169,659 |
421,567 |
220,781 |
59,662 |
应付托管费 |
350,898 |
126,470 |
66,234 |
17,899 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
15,203,575 |
12,566,501 |
1,677,041 |
1,719,807 |
负债合计 |
16,725,629 |
56,661,511 |
1,964,138 |
5,141,453 |
所有者权益 |
实收基金 |
5,177,266,022 |
2,138,266,022 |
760,266,022 |
243,266,022 |
未分配利润 |
-2,335,632,892 |
-941,012,831 |
-224,432,762 |
-78,579,596 |
所有者权益合计 |
2,841,633,130 |
1,197,253,191 |
535,833,260 |
164,686,426 |
负债和所有者权益总计 |
2,858,358,759 |
1,253,914,702 |
537,797,399 |
169,827,879 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。